Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
120mg/0.5ml glatiramer acetate2件: Acetate,
Glatiramer		---1件: 13 💬
240 mg glatiramer acetate2件: Acetate,
Glatiramer		---2件: 2, 13 💬
340 mg Glatiramer acetato1件: Glatiramer---1件: 13 💬
4Cyclophosphamide/Glatiramer acetate3件: Acetate,
Cyclophosphamide,
Glatiramer		2件: Cyclophosphamide ,
Cyclophosphamide 💬		--1件: 13 💬
5Experimental Glatiramer Acetate2件: Acetate,
Glatiramer		---1件: 13 💬
6Glatiramer1件: Glatiramer---4件: 2, 13, 96, 156 💬
7GLATIRAMER ACETATE2件: Acetate,
Glatiramer		---3件: 13, 96, 156 💬
8Glatiramer Acetate (Copaxone®)2件: Acetate,
Glatiramer		---2件: 13, 156 💬
9Glatiramer Acetate (DB)2件: Acetate,
Glatiramer		---1件: 13 💬
10Glatiramer Acetate (GA)2件: Acetate,
Glatiramer		---1件: 13 💬
11Glatiramer Acetate (GA) 40 mg2件: Acetate,
Glatiramer		---1件: 13 💬
12Glatiramer Acetate (GTR)2件: Acetate,
Glatiramer		---1件: 13 💬
13Glatiramer Acetate (OL)2件: Acetate,
Glatiramer		---1件: 13 💬
14Glatiramer acetate 150mg enteric coated tablets2件: Acetate,
Glatiramer		---1件: 13 💬
15Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets2件: Acetate,
Glatiramer		---1件: 13 💬
16Glatiramer acetate 20 mg2件: Acetate,
Glatiramer		---1件: 13 💬
17Glatiramer acetate 20 mg, with mitoxantrone3件: Acetate,
Glatiramer,
Mitoxantrone		1件: Mitoxantrone 💬2件: TOP2A,
TOP2B 💬		1件: Platinum drug resistance 💬1件: 13 💬
18Glatiramer Acetate 20 mg/0.5 mL2件: Acetate,
Glatiramer		---1件: 13 💬
19Glatiramer acetate 40 mg2件: Acetate,
Glatiramer		---1件: 13 💬
20Glatiramer Acetate [GA]2件: Acetate,
Glatiramer		---1件: 13 💬
21Glatiramer acetate injection with oral cetirizine hydrochloride3件: Acetate,
Cetirizine,
Glatiramer		1件: Cetirizine 💬1件: HRH1 💬3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬1件: 13 💬
22Glatiramer acetate with minocycline3件: Acetate,
Glatiramer,
Minocycline		1件: Minocycline 💬--1件: 13 💬
23Glatiramer acetate, (Copaxone®)2件: Acetate,
Glatiramer		---1件: 13 💬
24Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcutaneous), and IFN-beta 1b2件: Acetate,
Glatiramer		---1件: 13 💬
25Glatiramer Acetate, N-Acetylcysteine3件: Acetate,
Acetylcysteine,
Glatiramer		1件: Acetylcysteine 💬--1件: 13 💬
26GLATIRAMER ACETATO1件: Glatiramer---1件: 13 💬
27GLATIRAMERO ACETATO----1件: 13 💬
28Human interferon beta-1a and glatiramer acetate4件: Acetate,
Glatiramer,
Human interferon beta,
Interferon beta-1a		1件: Interferon beta-1a 💬2件: IFNAR1,
IFNAR2 💬		18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬1件: 13 💬
29Interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab12件: Acetate,
Alemtuzumab,
Cladribine,
Dimethyl fumarate,
Fingolimod,
Glatiramer,
Natalizumab,
Ocrelizumab,
Ofatumumab,
Ponesimod,
Rituximab,
Teriflunomide		10件: Cladribine ,
Alemtuzumab ,
Rituximab ,
Dimethyl fumarate ,
Ocrelizumab ,
Natalizumab ,
Ofatumumab ,
Fingolimod ,
Teriflunomide ,
Ponesimod 💬		7件: CD52,
DHODH,
ITGA4,
KEAP1,
MS4A1,
RRM1,
S1PR1 💬		30件: Arrhythmogenic right ventricular cardiomyopathy, Biosynthesis of cofactors, Cell adhesion molecules, Chemical carcinogenesis - reactive oxygen species, Dilated cardiomyopathy, Drug metabolism - other enzymes, ECM-receptor interaction, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Glutathione metabolism, Hematopoietic cell lineage, Hepatocellular carcinoma, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, PI3K-Akt signaling pathway, Parkinson disease, Pathways in cancer, Purine metabolism, Pyrimidine metabolism, Regulation of actin cytoskeleton, Sphingolipid signaling pathway, Ubiquitin mediated proteolysis, Yersinia infection 💬1件: 13 💬